Resolving mosaic trisomy 2 with discordant feto-placental monosomy 6: a case report with favorable outcome

Chromosomal mosaicism detected prenatally poses significant challenges for prognosis and genetic counseling, especially when involving rare chromosomes or discordant findings between fetus and placenta. We report a unique case of resolving mosaic trisomy 2 in the fetus with discordant mosaic monosomy 6 confined to the placenta, followed by a favorable outcome. A 32-year-old woman underwent amniocentesis at 20 weeks due to high-risk second-trimester maternal serum screening for Down syndrome. Initial CNV-seq revealed mosaic trisomy 2 (40%) and a 0.88 Mb deletion at 13q14.2q14.3 (seq[hg19]del(13)(q14.2q14.3)chr13:g.50760000_51640000del) of uncertain significance. Karyotyping was normal. Repeat amniocentesis at 24 weeks showed the trisomy 2 mosaicism had decreased to 2% by FISH (approximately 8% by concurrent CNV-seq), while the 13q deletion persisted. Prenatal ultrasounds showed only mild soft markers. The pregnancy continued to 39 + weeks, delivering a healthy male infant (birth weight 2.54 kg, Apgar 10). Postnatal analysis of 10 placental sites revealed mosaic monosomy 6 (5–10%) in 4 sites, while the 13q deletion was present in all placental sites and cord blood. No chromosome 2 or 6 abnormalities were detected in cord blood. STR analysis excluded maternal cell contamination, and ROH analysis excluded uniparental disomy. This case demonstrates that mosaic trisomy 2 can resolve spontaneously in utero and may be associated with a favorable postnatal outcome despite discordant feto-placental aneuploidy (trisomy 2 in fetus, monosomy 6 in placenta). It underscores the dynamic nature of mosaicism, the importance of multimodal diagnostic approaches, and the need for cautious, informed genetic counseling.

Authors

Publication Details

Journal
Molecular Cytogenetics
Published
2026-11-19
DOI
https://doi.org/10.1186/s13039-026-00790-3
Primary Topic
Prenatal Screening and Diagnostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Resolving mosaic trisomy 2 with discordant feto-placental monosomy 6: a case report with favorable outcome

Haiyan Ou, Qianggui Wu, Jinfang Li, Faqiang Chen et al.
Molecular Cytogenetics
Prenatal Screening and Diagnostics
article

Resolving mosaic trisomy 2 with discordant feto-placental monosomy 6: a case report with favorable outcome

Haiyan Ou, Qianggui Wu, Jinfang Li, Faqiang Chen, Chuanyong Liu, Peisi Li
article en

Abstract

Chromosomal mosaicism detected prenatally poses significant challenges for prognosis and genetic counseling, especially when involving rare chromosomes or discordant findings between fetus and placenta. We report a unique case of resolving mosaic trisomy 2 in the fetus with discordant mosaic monosomy 6 confined to the placenta, followed by a favorable outcome. A 32-year-old woman underwent amniocentesis at 20 weeks due to high-risk second-trimester maternal serum screening for Down syndrome. Initial CNV-seq revealed mosaic trisomy 2 (40%) and a 0.88 Mb deletion at 13q14.2q14.3 (seq[hg19]del(13)(q14.2q14.3)chr13:g.50760000_51640000del) of uncertain significance. Karyotyping was normal. Repeat amniocentesis at 24 weeks showed the trisomy 2 mosaicism had decreased to 2% by FISH (approximately 8% by concurrent CNV-seq), while the 13q deletion persisted. Prenatal ultrasounds showed only mild soft markers. The pregnancy continued to 39 + weeks, delivering a healthy male infant (birth weight 2.54 kg, Apgar 10). Postnatal analysis of 10 placental sites revealed mosaic monosomy 6 (5–10%) in 4 sites, while the 13q deletion was present in all placental sites and cord blood. No chromosome 2 or 6 abnormalities were detected in cord blood. STR analysis excluded maternal cell contamination, and ROH analysis excluded uniparental disomy. This case demonstrates that mosaic trisomy 2 can resolve spontaneously in utero and may be associated with a favorable postnatal outcome despite discordant feto-placental aneuploidy (trisomy 2 in fetus, monosomy 6 in placenta). It underscores the dynamic nature of mosaicism, the importance of multimodal diagnostic approaches, and the need for cautious, informed genetic counseling.

Molecular Cytogenetics
Prenatal Screening and Diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon